- Home
- SHMD vs ANVS Comparison
SHMD vs ANVS Comparison
Compare SHMD & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- ANVS
- Stock Information
- Founded
- SHMD 1864
- ANVS 2008
- Country
- SHMD Germany
- ANVS United States
- Employees
- SHMD N/A
- ANVS N/A
- Industry
- SHMD
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- SHMD
- ANVS Health Care
- Exchange
- SHMD Nasdaq
- ANVS Nasdaq
- Market Cap
- SHMD 102.1M
- ANVS 48.3M
- IPO Year
- SHMD N/A
- ANVS 2020
- Fundamental
- Price
- SHMD $2.22
- ANVS $2.32
- Analyst Decision
- SHMD
- ANVS Strong Buy
- Analyst Count
- SHMD 0
- ANVS 4
- Target Price
- SHMD N/A
- ANVS $17.33
- AVG Volume (30 Days)
- SHMD 30.8K
- ANVS 198.0K
- Earning Date
- SHMD 01-01-0001
- ANVS 11-07-2025
- Dividend Yield
- SHMD N/A
- ANVS N/A
- EPS Growth
- SHMD N/A
- ANVS N/A
- EPS
- SHMD N/A
- ANVS N/A
- Revenue
- SHMD $85,165,542.00
- ANVS N/A
- Revenue This Year
- SHMD N/A
- ANVS N/A
- Revenue Next Year
- SHMD N/A
- ANVS N/A
- P/E Ratio
- SHMD N/A
- ANVS N/A
- Revenue Growth
- SHMD N/A
- ANVS N/A
- 52 Week Low
- SHMD $1.86
- ANVS $1.11
- 52 Week High
- SHMD $4.40
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- SHMD 37.92
- ANVS 43.70
- Support Level
- SHMD $2.00
- ANVS $2.26
- Resistance Level
- SHMD $2.48
- ANVS $2.51
- Average True Range (ATR)
- SHMD 0.21
- ANVS 0.11
- MACD
- SHMD -0.02
- ANVS 0.01
- Stochastic Oscillator
- SHMD 30.07
- ANVS 35.48
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.